Documentation Index
Fetch the complete documentation index at: https://docs.encoreos.io/llms.txt
Use this file to discover all available pages before exploring further.
Version: 2.0.0
Last Updated: 2026-05-15
Source: CL-PM-SPEC-REVIEW Finding 4.4, ONC 21st Century Cures Act, May 2026 Compass Artifact Analysis
Owner: Product / Compliance / CL / PM / PF
This document maps Encore Health OS specs to ONC Health IT Certification criteria (45 CFR Part 170), provides a trigger-based escalation framework, and integrates competitive landscape findings.
Strategic Recommendation: Alignment-Only → Modular → Full
Current path: Alignment-Only. Build to ONC criteria without formal certification filing. Certify when a named trigger event fires.
| Path | Cost | Timeline | Annual Maint. | Fit for Encore |
|---|
| Alignment-Only | $0 external; ~500–1,000 hrs internal | Continuous | $0 | Current path |
| Modular (e.g., (g)(10)/(g)(31)) | ~150K–300K | 9–12 months from kickoff | ~30K–80K | When trigger fires |
| Full / Base EHR | 400K–1M+ | 18–24 months | 100K–250K | Not before Series A |
Trigger Events (Alignment → Modular)
- Named AHCCCS-contracted ACC-RBHA or CARF/Joint Commission-accredited multi-state SUD chain writes “ONC-certified CEHRT” into mandatory RFP requirements
- Clinical AI feature ships that triggers HTI-1 §170.315(b)(11) DSI transparency obligations
- Encore wins a TI 2.0 cohort or AHCCCS RHTP subaward where EHR functionality is scored
- Information blocking enforcement materially escalates ($1M per violation CMPs are live; joint HHS-OIG/ASTP enforcement alert issued September 4, 2025)
Trigger Events (Modular → Full)
- Large hospital-affiliated psychiatric customer requires CEHRT for Medicare hospital PI reporting
- Multi-state expansion into Medicaid programs with active PI-successor incentives
- HTI-5 re-introduces Patient Access API requirements
Competitive Landscape
Of 11 named BH EHR competitors, 10 are ONC-certified. Certification is table stakes for enterprise BH EHR.
| Vendor | ONC Certified | Notes |
|---|
| Kipu Health | Yes | Also HITRUST-certified; ISO 42001 AI management |
| Sigmund AURA | Yes | HIPAA + SOC 2 Type II + ONC |
| AZZLY Rize | Yes | Includes EPCS for MAT |
| Lightning Step | Yes | BH-only platform |
| Procentive (Ensora Health) | Yes | Ensora portfolio |
| TenEleven eCR (Ensora) | Yes | Ensora-owned |
| EchoVantage (Ensora) | Yes | Ensora portfolio |
| ICANotes | Yes | Built for BH |
| Qualifacts (4 products) | Yes | Largest BH vendor by certification footprint |
| EHRYourWay (Adaptamed) | Yes | SLI Compliance certified |
| BestNotes | No | Smaller practices/SUD focus |
Readiness Scores
| Area | Score | Target (6 mo) |
|---|
| API foundation (g)(10) track | 2.5 / 5.0 | 4.0 |
| Information blocking operations | 2.0 / 5.0 | 3.5 |
| C-CDA and transitions | 2.0 / 5.0 | 3.0 |
| eRx track | 2.0 / 5.0 | 2.5 |
| Public health criteria | 0.5 / 5.0 | 1.0 |
| Conditions/Maintenance | 1.0 / 5.0 | 2.0 |
| Overall Certification Readiness | 1.8 / 5.0 | 3.0 |
| Overall Alignment Posture | 2.5 / 5.0 | 4.0 |
Note: Alignment score revised from 3.0 to 2.5 per May 2026 analysis — USCDI v3 is now the baseline and most BH competitors already meet that bar.
Mapping: Encore Health OS Specs to ONC Criteria
| ONC Criterion | Description | Encore Health OS Spec(s) | Status |
|---|
| §170.315(a)(1)–(3) | CPOE (meds, lab, imaging) | CL-05, CL-06, CL-09 | Spec + partial impl |
| §170.315(a)(4) | Drug-drug/allergy checks | CL-06, CL-45 | Spec + partial impl |
| §170.315(a)(5) | Demographics | PM-01, PM-55 | Spec + partial impl |
| §170.315(a)(6) | Problem list | CL-46 | Spec + partial impl |
| §170.315(a)(7) | Medication list | CL-05 | Spec + partial impl |
| §170.315(a)(8) | Medication allergy list | CL-45 | Spec + partial impl |
| §170.315(a)(9) | Clinical decision support | CL-08 | Spec + partial impl |
| §170.315(a)(14) | Implantable device list | N/A (BH focus) | N/A |
| §170.315(a)(15) | SDOH/behavioral data | CL-18, CL-40 | Spec + partial impl |
| §170.315(b)(1)–(2) | Transitions of care / reconciliation | CL-48, CL-12, CL-05 | Spec + partial impl |
| §170.315(b)(3) | E-prescribing | CL-06 | Spec + partial impl |
| §170.315(b)(6) | Data export | PF-44, CL-20 | Spec + partial impl |
| §170.315(b)(7)/(b)(8) | DS4P send/receive | CL-63 (new) | Not Started |
| §170.315(b)(10) | EHI export | PF-44, PM-55 | Spec + partial impl |
| §170.315(b)(11) | DSI transparency | CL-65 (new), PM-64, CL-08 | Spec-only |
| §170.315(c)(1)–(4) | CQM record/import/report/filter | CL-51 | Spec-only |
| §170.315(d)(1)–(13) | Privacy and security | PF-01, PF-30, PF-91, CL-11 | Mixed |
| §170.315(e)(1) | VDT (View, Download, Transmit) | PM-12, PM-55, CL-16 | Spec + partial impl |
| §170.315(f)(1) | Immunization registry (ASIIS) | CL-66 (new) | Not Started |
| §170.315(f)(5) | eCR reportable conditions | CL-67 (new) | Not Started |
| §170.315(g)(7)–(9) | Application access APIs | CL-16, PM-55 | Spec + partial impl |
| §170.315(g)(10) | Standardized FHIR R4 API | CL-16, CL-16-EN-02, PM-55 | Spec + partial impl |
| §170.315(h)(1)–(2) | Direct transport | CL-48, PM-14 | Spec + partial impl |
| USCDI v3 | Demographics, problems, meds, etc. | PM-01, CL-01, CL-04, CL-05, CL-10 | Partial |
Parallel Tracks (Non-ONC but Critical)
| Track | Spec | Priority | Status |
|---|
| DEA EPCS (21 CFR 1311) | CL-64 (new) | P1 — required for MAT | Not Started |
| Contexture HIE | PF-108 (new) | P1 — AHCCCS DAP 8.0% | Not Started |
| EKRA compliance | PF-107 (new) | P0 — NorthSight risk | Not Started |
| HITRUST e1 | PF-109 (new) | P2 — Kipu parity | Not Started |
| USCDI+ BH profiles | CL-16-EN-03 (new) | P2 — proactive | Not Started |
| Surescripts certification | PM-73 (new) | P3 — production eRx | Not Started |
| SAMHSA reporting | GR-26 (new) | P3 — grant compliance | Not Started |
Gaps and Priorities
- USCDI v3 alignment: All FHIR resources must target USCDI v3 (baseline as of Jan 1, 2026). US Core 6.1.0 profiles are the conformance target.
- DS4P for Part 2: CL-63 must implement confidentiality coding before any production FHIR exchange involving SUD data.
- FHIR R4 API (g)(10): CL-16 + PM-55 must complete SMART App Launch v2, CapabilityStatement, and Inferno-passing conformance.
- Information blocking: PM-55 must complete denial taxonomy, review queue, and annual governance packet.
- DEA EPCS: CL-64 is prerequisite for MAT prescribing — half the AHCCCS-funded SUD market.
- Contexture/HIE: PF-108 is the single highest-ROI Arizona-specific move — DAP incentives flow through Contexture.
- DSI transparency: CL-65 required before shipping AI clinical features to avoid HTI-1 compliance exposure.
- EKRA: PF-107 is P0 — shared-founder NorthSight relationship requires immediate legal review.
Phased Timeline
| Phase | Focus | Target |
|---|
| Days 0–30 | Contexture agreement; NLM UMLS license; EKRA legal memo; USCDI v3 data model alignment; HITRUST e1 scoping | Immediate |
| Days 31–90 | FHIR R4 USCDI v3 endpoints + SMART v2; DS4P coding; DAP SOW submission; HITRUST e1 readiness | 90 days |
| Months 4–6 | HITRUST e1 assessment; Contexture live exchange; Inferno-passing (g)(10) alignment; first DSI disclosure | 6 months |
| Months 6–12 | Trigger decision gate; HITRUST i1 readiness; DEA EPCS engagement; USCDI+ BH pilot mapping | 12 months |
| Months 12–24 | If triggered: Drummond engagement for modular certification | 24 months |
References